Item Type | Name |
Concept
|
Carcinoma, Non-Small-Cell Lung
|
Concept
|
Carcinoma
|
Concept
|
Carcinoma, Renal Cell
|
Concept
|
Carcinoma, Squamous Cell
|
Concept
|
Carcinoma, Neuroendocrine
|
Concept
|
Carcinoma, Large Cell
|
Concept
|
Carcinoma, Bronchogenic
|
Concept
|
Carcinoma, Small Cell
|
Concept
|
Small Cell Lung Carcinoma
|
Academic Article
|
Value of circulating insulin-like growth factor-associated proteins for the detection of stage I non-small cell lung cancer.
|
Academic Article
|
50th Anniversary Landmark Commentary on Jensik RJ, Faber LP, Kittle CF. Segmental resection for bronchogenic carcinoma. Ann Thorac Surg 1979;28:475-83.
|
Academic Article
|
Status of sentinel lymph node mapping in non-small cell lung cancer.
|
Academic Article
|
Age is a strong risk factor for atrial fibrillation after pulmonary lobectomy.
|
Academic Article
|
Survival Benefit of Surgery after Chemoradiotherapy for Stage III (N0-2) Non-Small-Cell Lung Cancer Is Dependent on Pathologic Nodal Response.
|
Academic Article
|
Prospective analysis of pneumonectomy: risk factors for major morbidity and cardiac dysrhythmias.
|
Academic Article
|
Split-course chemoradiotherapy for locally advanced non-small cell lung cancer: a single-institution experience of 144 patients.
|
Academic Article
|
Influence of conformal radiotherapy technique on survival after chemoradiotherapy for patients with stage III non-small cell lung cancer in the National Cancer Data Base.
|
Academic Article
|
PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients.
|
Academic Article
|
Intraoperative sentinel node mapping with technitium-99 in lung cancer: results of CALGB 140203 multicenter phase II trial.
|
Academic Article
|
Critical factors for patient management.
|
Academic Article
|
An historical perspective of multi-modality treatment for resectable non-small cell lung cancer.
|
Academic Article
|
Complications from induction regimens for thoracic malignancies. Perioperative considerations.
|
Academic Article
|
CDKN2A (p16) promoter hypermethylation influences the outcome in young lung cancer patients.
|
Academic Article
|
Cytologic features of adult spindle cell variant of rhabdomyosarcoma: a report of two cases.
|
Academic Article
|
A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer.
|
Academic Article
|
Pneumonectomy after chemoradiation therapy for non-small cell lung cancer: does "side" really matter?
|
Academic Article
|
Biomarkers of the insulin-like growth factor pathway predict progression and outcome in lung cancer.
|
Academic Article
|
Prognostic value of xanthine oxidoreductase expression in patients with non-small cell lung cancer.
|
Academic Article
|
A multi-analyte serum test for the detection of non-small cell lung cancer.
|
Academic Article
|
Establishment of a multi-analyte serum biomarker panel to identify lymph node metastases in non-small cell lung cancer.
|
Academic Article
|
Neoadjuvant chemoradiation for clinically advanced non-small cell lung cancer: an analysis of 233 patients.
|
Academic Article
|
Enhancement of a multianalyte serum biomarker panel to identify lymph node metastases in non-small cell lung cancer with circulating autoantibody biomarkers.
|
Academic Article
|
Metformin exposure is associated with improved progression-free survival in diabetic patients after resection for early-stage non-small cell lung cancer.
|
Academic Article
|
Sentinel node mapping in lung cancer.
|
Academic Article
|
Endobronchial colorectal metastasis versus primary lung cancer: a tale of two sleeve right upper lobectomies.
|
Academic Article
|
Intraoperative radioisotope sentinel lymph node mapping in non-small cell lung cancer.
|
Academic Article
|
Relationship Between Radiation Therapy Dose and Outcome in Patients Treated With Neoadjuvant Chemoradiation Therapy and Surgery for Stage IIIA Non-Small Cell Lung Cancer: A Population-Based, Comparative Effectiveness Analysis.
|
Academic Article
|
Prevalence and predictors of neoadjuvant therapy for stage IIIA non-small cell lung cancer in the National Cancer Database: importance of socioeconomic status and treating institution.
|
Academic Article
|
Development of a serum biomarker panel predicting recurrence in stage I non-small cell lung cancer patients.
|
Academic Article
|
Prognostic significance of weight gain during definitive chemoradiotherapy for locally advanced non-small-cell lung cancer.
|
Academic Article
|
Cytologic imprints of giant atypical bronchopulmonary carcinoid tumor of the lung with extensive oncocytic component.
|
Academic Article
|
Number of Ribs Resected is Associated with Respiratory Complications Following Lobectomy with en bloc Chest Wall Resection.
|
Academic Article
|
Smaller incisions for smaller cancers.
|
Academic Article
|
Wedge resection versus lobectomy for stage I (T1 N0 M0) non-small-cell lung cancer.
|
Academic Article
|
Comparative effectiveness of neoadjuvant chemoradiotherapy versus chemotherapy alone followed by surgery for patients with stage IIIA non-small cell lung cancer.
|
Academic Article
|
Weight gain in advanced non-small-cell lung cancer patients during treatment with split-course concurrent chemoradiotherapy is associated with superior survival.
|
Academic Article
|
Contemporary review on the inequities in the management of lung cancer among the African-American population.
|
Academic Article
|
Bilobectomy for non-small cell lung cancer: a search for clinical factors that may affect perioperative morbidity and long-term survival.
|
Academic Article
|
The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy.
|
Academic Article
|
Esophageal carcinoma advances in treatment results for locally advanced disease: review.
|
Academic Article
|
Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of non-small cell lung cancer.
|
Academic Article
|
Angiogenesis Biomarkers May Be Useful in the Management of Patients With Indeterminate Pulmonary Nodules.
|
Academic Article
|
Repeat pulmonary resection for metachronous colorectal carcinoma is beneficial.
|
Academic Article
|
Serum Biomarkers May Prognosticate Recurrence in Node-Negative, Non-Small Cell Lung Cancers Less Than 4 Centimeters.
|
Academic Article
|
Reply.
|
Academic Article
|
Development of bead based multiplexed immunoassay for evaluation of midkine, syndecan-1, and ANGPTL4 in patient serum.
|
Academic Article
|
Circulating histocompatibility antigen (HLA) gene products may help differentiate benign from malignant indeterminate pulmonary lesions.
|
Academic Article
|
Improved False-Positive Rates and the Overestimation of Unintended Harm from Lung Cancer Screening.
|
Academic Article
|
Redefining the Risk of Surgery for Clinical Stage IIIA (N2) Non-Small Cell Lung Cancer: A Pooled Analysis of the STS GTSD and ESTS Registry.
|
Academic Article
|
Definition and assessment of high risk in patients considered for lobectomy for stage I non-small cell lung cancer: The American Association for Thoracic Surgery expert panel consensus document.
|